Opexa Therapeutics (OPXA) Files 1.7M Common Shelf for Shareholders
Tweet
Share
E-mailGet Alerts OPXA Hot Sheet
Join SI Premium – FREE
Opexa Therapeutics (NASDAQ: OPXA) filed a registration with the U.S. SEC to sell, from time to time, up to 1,702,740 shares of Common Stock on behalf of selling shareholders.
Opexa will not received proceeds from the secondary offering.
Opexa will not received proceeds from the secondary offering.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Singularity Future Technology closes $5M registered direct offering
- RenovoRx regains Nasdaq minimum bid price compliance
- Gossamer Bio raises up to $250M in private placement for PAH drug
Create E-mail Alert Related Categories
Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
